Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Frequently asked questions
What sector does Global Cord Blood Corporation (CO) operate in?
Global Cord Blood Corporation belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Global Cord Blood Corporation (CO) current stock price?
As of the latest data, Global Cord Blood Corporation stock price is $0.00, with a previous close of $0.00.
What is Global Cord Blood Corporation (CO) Earnings Per Share (EPS)?
The trailing EPS is $0.59.
What is Global Cord Blood Corporation (CO) EBITDA?
Global Cord Blood Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 142.14 million.
Does Global Cord Blood Corporation (CO) pay dividends?
No. Global Cord Blood Corporation does not pay a dividend.
When is Global Cord Blood Corporation (CO) next earnings report?
Global Cord Blood Corporation is expected to release its next earnings report on June 30, 2023.
What is Global Cord Blood Corporation (CO) beta (volatility) score?
Global Cord Blood Corporation has a beta of -0.400, indicating lower volatility than the overall market.
